Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New vaccine protects against two Salmonella strains
chickens
The new vaccine protects against S Enteritidis and S Typhimurium in the same vial.
Vaccine will also be licensed for use in turkeys and ducks for the first time

Poultry producers will be able to protect their stock against two strains of Salmonella simultaneously, thanks to the arrival of a new vaccine on the market.

Salmonella is a significant cause of food poisoning in humans, caught from contaminated meat and eggs. Food-borne disease caused by the bacteria is estimated to affect tens of millions of people worldwide each year, according to the World Health Organisation. It is also responsible for severe economic losses in the poultry industry.

The new live vaccine, AviPro Salmonella Duo, is the first to protect against both S Enteritidis and S Typhimurium in the same vial. Globally, these are the two most significant Salmonella strains passed from animals to humans. It is also the first vaccine to be licensed for use in turkeys and ducks as well as chickens.

According to Elanco Animal Health, who launched the product, the new vaccine provides an extra eight weeks of immunity compared to previous vaccines - 62 weeks' immunity for S Typhimurium and 68 weeks for S Enteritidis.

AviPro is administered in drinking water rather than by injection, which Elanco says improves animal welfare, allowing mass administration without causing stress to the birds.

To find out more about the vaccine, visit: http://salmonella360.com/

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.